• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » St. Jude Medical ticks up on Q2 sales beat

St. Jude Medical ticks up on Q2 sales beat

July 20, 2016 By Brad Perriello

St. Jude MedicalSt. Jude Medical (NYSE:STJ) shares are up today after the medical device company reported higher-than-expected sales for the 2nd quarter and met Wall Street’s consensus earnings forecast.

Little Canada, Minn.-based St. Jude posted profits of $238 million, or 83¢ per share, on sales of $1.56 billion for the 3 months ended July 2, for a bottom-line slide of -17.9% on sales growth of 10.8%.

Adjusted to exclude 1-time items, earnings per share were $1.06, dead even with expectations on The Street, where analysts were looking for sales of $1.55 billion.

Investors reacted to the earnings report by pushing STJ shares up a tick in pre-market trading, for a 0.7% gain to $80.80 per share. The stock was up 1.1% to $81.08 apiece in early-morning activity.

“We continued to build momentum during the 2nd quarter by bringing innovative products to our global markets. The strong performance in international sales gives us confidence that where we have a full portfolio, we can deliver top-tier growth. One of the major highlights of our quarter was the announcement of our pending merger with Abbott (NYSE:ABT). We continue to be confident and excited about the potential of our combined organization and the powerful impact we can have on delivering industry leading innovation to physicians and patients around the world,” president & CEO Michael Rousseau said in prepared remarks.

Abbott agreed in April to pay $25 billion for St. Jude; today, the latter said it’s suspending its guidance in light of the impending merger. Earlier this month the companies added 30 days to the expected closing date for the deal, after U.S. anti-trust regulators asked for more information on the proposed tie-up.

The $85-per-share deal consists of $46.75 in cash and 0.8708 ABT shares; at Abbott’s 5-day volume weighted average share price of $43.93 as of April 26, the buyout is worth about $25 billion. That’s a 37% premium on the closing price of $61.97 for STJ shares the day before the acquisition was revealed.

Filed Under: MassDevice Earnings Roundup, Wall Street Beat Tagged With: stjudemedical

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy